National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 7) (PB 74 of 2017) (Cth)

PB 74 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 7)

National Health Act 1953

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 19 September 2017

JULIANNE QUAINE

First Assistant Secretary (Acting)

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 7)

(2)This Instrument may also be cited as PB 74 of 2017.

2          Commencement

This Instrument commences on 1 October 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, after entry for Atorvastatin and ezetimibe in the form Pack containing 30 tablets atorvastatin 80 mg (as calcium) and
   30 tablets ezetimibe 10 mg

insert:

Auranofin Capsule 3 mg 20 60 5

1. Schedule 1, after entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

insert:

Brexpiprazole	Tablet 1 mg	20	30	0
Brexpiprazole	Tablet 2 mg	20	30	5
Brexpiprazole	Tablet 3 mg	20	30	5
Brexpiprazole	Tablet 4 mg	20	30	5